Drug Patent Expirations for Jul 21, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

VALTREX (valacyclovir hydrochloride)
Glaxosmithkline
Patent number:6,107,302
Expiration Date:Jul 19, 2016

VALTREX (valacyclovir hydrochloride)
Glaxosmithkline
Patent number:5,879,706
Expiration Date:Jul 19, 2016

POMALYST (pomalidomide)
Celgene
Patent number:5,635,517
Expiration Date:Jul 24, 2016

POMALYST (pomalidomide)
Celgene
Patent number:6,476,052
Expiration Date:Jul 24, 2016

REVLIMID (lenalidomide)
Celgene
Patent number:6,281,230
Expiration Date:Jul 24, 2016

REVLIMID (lenalidomide)
Celgene
Patent number:6,555,554
Expiration Date:Jul 24, 2016

REVLIMID (lenalidomide)
Celgene
Patent number:7,119,106
Expiration Date:Jul 24, 2016

REVLIMID (lenalidomide)
Celgene
Patent number:8,288,415
Expiration Date:Jul 24, 2016

DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.

For more information try a trial


Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: